Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma

Leukemia, Published online: 14 February 2020; doi:10.1038/s41375-020-0743-ySingle-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma

Source: Leukemia - February 13, 2020 Category: Hematology Authors: Georg Lenz Eliza Hawkes Gregor Verhoef Corinne Haioun Soon Thye Lim Dae Seog Heo Kirit Ardeshna Geoffrey Chong Jacob Haaber Wei Shi Igor Gorbatchevsky Susanne Lippert Florian Hiemeyer Paolo Piraino Georg Beckmann Carol Pe ña Viktoriya Buvaylo Barrett H. Source Type: research